In fact, a wide range of glycosylation alterations have been associated with pancreatic cancer such as increased expression of SLex antigen, increased expression of truncated O‐glycans (Tn and STn), increased branched and fucosylated N‐glycans, upregulation of specific proteoglycans and galectins, and increased O‐GlcNAcylation (Figure 1) [123]. This evidence concerns the gene EEF1A2 and pancreatic neoplasm.